We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39B
AUM Growth
-$220M
(-0.56%)
Cap. Flow
+$1.59B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,663
New
306
Increased
844
Reduced
1,189
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$592M |
| 2 |
Tesla
TSLA
|
+$492M |
| 3 |
Amazon
AMZN
|
+$474M |
| 4 |
Advanced Micro Devices
AMD
|
+$410M |
| 5 |
Qualcomm
QCOM
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$393M |
| 2 |
Union Pacific
UNP
|
+$363M |
| 3 |
Walmart Inc
WMT
|
+$239M |
| 4 |
Citigroup
C
|
+$192M |
| 5 |
ConocoPhillips
COP
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.84% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Industrials | 10.47% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Vir Biotechnology
VIR
$1.45B
| $149K | ﹤0.01% |
+15,900
| New | +$227K |
|
2152
Clarus
CLAR
$126M
| $149K | ﹤0.01% |
19,661
+5,261
| +37% | +$42.1K |
|
2153
Quince Therapeutics
QNCX
$20.3M
| $148K | ﹤0.01% |
660
-296
| -31% | -$77.3K |
|
2154
China Yuchai International
CYD
$1.67B
| $147K | ﹤0.01% |
14,590
-100
| -0.7% | -$1.09K |
|
|
BRDG
2155
DELISTED
Bridge Investment Group
BRDG
| $146K | ﹤0.01% |
+15,900
| New | +$176K |
|
2156
Bit Digital
BTBT
$424M
| $146K | ﹤0.01% |
68,300
+25,800
| +61% | +$81K |
|
2157
Curis
CRIS
$9.67M
| $146K | ﹤0.01% |
1,106
-161
| -13% | -$41.4K |
|
2158
Omeros
OMER
$835M
| $146K | ﹤0.01% |
49,900
+11,300
| +29% | +$45.3K |
|
2159
Century Casinos
CNTY
$32.6M
| $144K | ﹤0.01% |
28,100
-16,600
| -37% | -$112K |
|
|
TSE
2160
DELISTED
Trinseo
TSE
| $141K | ﹤0.01% |
+17,200
| New | +$218K |
|
2161
CytomX Therapeutics
CTMX
$690M
| $139K | ﹤0.01% |
107,900
-121,500
| -53% | -$191K |
|
2162
AtaiBeckley Inc
ATAI
$2.66B
| $139K | ﹤0.01% |
107,500
-60,800
| -36% | -$104K |
|
2163
Douglas Elliman
DOUG
$158M
| $138K | ﹤0.01% |
+60,915
| New | +$140K |
|
|
WOW
2164
DELISTED
WideOpenWest
WOW
| $137K | ﹤0.01% |
17,900
+4,400
| +33% | +$34.9K |
|
|
PNT
2165
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $135K | ﹤0.01% |
20,200
-142,500
| -88% | -$1.18M |
|
2166
Driven Brands
DRVN
$2.49B
| $135K | ﹤0.01% |
10,700
-9,600
| -47% | -$176K |
|
|
AHRT
2167
AH Realty Trust
AHRT
$539M
| $134K | ﹤0.01% |
13,100
-24,500
| -65% | -$284K |
|
2168
Neurogene
NGNE
$648M
| $134K | ﹤0.01% |
8,470
-755
| -8% | -$11.1K |
|
|
VZIO
2169
DELISTED
VIZIO Holding Corp.
VZIO
| $130K | ﹤0.01% |
+24,100
| New | +$155K |
|
2170
3D Systems Corp
DDD
$402M
| $130K | ﹤0.01% |
26,400
-39,200
| -60% | -$281K |
|
2171
Citizens
CIA
$254M
| $129K | ﹤0.01% |
45,187
| – | – |
|
|
CELL
2172
DELISTED
PhenomeX Inc. Common Stock
CELL
| $128K | ﹤0.01% |
128,568
-278,885
| -68% | -$214K |
|
|
DLA
2173
DELISTED
Delta Apparel Inc.
DLA
| $128K | ﹤0.01% |
19,300
-1,400
| -7% | -$11.3K |
|
|
DESP
2174
DELISTED
Despegar.com
DESP
| $126K | ﹤0.01% |
17,400
-8,100
| -32% | -$61.4K |
|
2175
Broadwind
BWEN
$87.5M
| $126K | ﹤0.01% |
39,400
-34,200
| -46% | -$130K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, Two Sigma Advisers held 2,663 positions worth $39B, down 0.56% from $39.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Two Sigma Advisers deployed $1.59B of net new capital in Q3 2023, opening 306 new positions and adding to 844 existing holdings. Its largest new stake was Advanced Micro Devices: 3,777,240 shares worth $388M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $393M trimmed.
- Two Sigma Advisers's largest Q3 2023 buy was Advanced Micro Devices: 3,777,240 shares worth $388M.
- Two Sigma Advisers added most to Microsoft in Q3 2023, an estimated $592M increase.
- Two Sigma Advisers's biggest Q3 2023 reduction was Charles Schwab, cutting an estimated $393M.
- Two Sigma Advisers fully exited Uber in Q3 2023, selling an estimated $109M.
- Two Sigma Advisers's ten largest holdings make up 16% of its $39B portfolio in Q3 2023.
- Two Sigma Advisers opened 306 new positions and closed 301 in Q3 2023.
- Two Sigma Advisers's portfolio value fell 0.56% quarter-over-quarter to $39B.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.